Now commonly prescribed to patients, this category of drug is usually available in tablet form. While there are two general types of benzodiazepines, hypnotics and anxiolytics, there are now many different kinds and brands of benzos out there.
Some brand names for benzodiazepine medications include:. They are each prescribed at varied rates and for different disorders. Some benzodiazepines, unfortunately, are distributed and consumed illegally because of their addictive properties.
Short-term use of benzodiazepines, since it is intended for medical purposes, should only cause mild side effects. The possibility of mild cognitive decline with long-term exposure needs further investigation. Molecular and neuronal substrate for the selective attenuation of anxiety. American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?
Prescriber intent, off-label usage, and early discontinuation of antidepressants: a retrospective physician survey and data analysis. Stahl SM. Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
Benzodiazepine use and the risk of motor vehicle crash in the elderly. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.
Chronic use of benzodiazepines and psychomotor and cognitive test performance. Practice guidelines for the treatment of patients with panic disorder.
Work Group on Panic Disorder. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.
Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications, IV: therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorder. Clinical aspects of the chronic use of alprazolam and lorazepam. Lack of relationship between long-term use of benzodiazepines and escalation to high dosages.
Long-term benzodiazepine therapy does not result in brain abnormalities. Dose- dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders.
Ashton CH. Benzodiazepines: how they work and how to withdraw. Accessed on April 23, Pharmacological interventions for benzodiazepine monodependence management in outpatient settings. Risk Versus Benefit of Benzodiazepines. August 1, Jay M. Pomerantz, MD. Mechanism of action Benzodiazepines bind stereospecifically to unique portions of GABA receptors that are large protein complexes located on certain neurons in the CNS.
Cognitive impairment Cognitive impairment from long-term use of benzodiazepines is an issue that is drawing increasing attention. There are others, however, who have seen the pandemic as a precious window of time, a once-in-a-lifetime opportunity to change.
Somehow, I am one of them. One day in September, I quit alcohol, cigarettes and animal products, and started tapering off benzodiazepines, all at once.
I have now been completely benzo-free for more than a month. I recommend you consult a doctor before you consider stopping any medications. The external Covid crisis made quelling my internal one a real possibility. The same pursuit of extreme states of consciousness that led me to drugs in the first place could help lead me out.
It helped that the conditions imposed by the pandemic were ideal for withdrawal. That rate of long-term use is concerning enough in itself, says Lauren Gerlach, D. Gerlach points to two other concerning findings from the review of records and detailed interviews with program participants. Long-term benzodiazepine users were no more likely to have a diagnosis of anxiety, which is sometimes an indication for long-term use.
Also, long-term users were more likely to say they had sleep problems, despite the fact that benzodiazepines are not recommended for long-term use as sleep aids and may even worsen sleep the longer they are used.
The program provides a supplement to a Pennsylvania medication coverage program for low-income older adults. The program provides behavioral health and case management services by telephone across the state.
All of the patients in the study live at home or in other community settings, so the study does not include patients in nursing homes and other skilled nursing facilities.
0コメント